Blockchain This Week: India’s First Ever Covid-19 Tracking Blockchain Platform & More

Blockchain This Week: India’s First Ever Covid-19 Tracking Blockchain Platform & More

Covid-19 tracking blockchain platform BeiYo can be integrated with Aarogya Setu The blockchain-powered platform can be used issue certificates for Covid-19 clinical records and immunisation certificates on blockchain at a cost price of INR 20 Coca Cola’s bottling supply chain company Coke One North America (CONA) services to leverage blockchain to enhance efficiency In a … Read more Blockchain This Week: India’s First Ever Covid-19 Tracking Blockchain Platform & More

India's COVID-19 Recovery Rate Rises To 67.19 Per Cent: Government

India's COVID-19 Recovery Rate Rises To 67.19 Per Cent: Government

COVID-19 case fatality rate has been progressively falling: Ministry (Representational) New Delhi: A total of 51,706 patients have recuperated from COVID-19 in India in a span of 24 hours, the highest in a day, pushing the recovery rate to 67.19 per cent on Wednesday while the case fatality rate has further dropped to 2.09 per … Read more India's COVID-19 Recovery Rate Rises To 67.19 Per Cent: Government

COVID-19: Shivraj Singh Chouhan "Asymptomatic", Discharged From Hospital

COVID-19: Shivraj Singh Chouhan "Asymptomatic", Discharged From Hospital

Madhya Pradesh Chief Minister Shivraj Chouhan has been “asymptomatic for the past 10 days” Bhopal: Madhya Pradesh Chief Minister Shivraj Singh Chouhan was discharged from a private hospital in Bhopal today after recovering from coronavirus infection, an official said. Doctors have advised Mr Chouhan, who was in the hospital for 11 days, to stay in … Read more COVID-19: Shivraj Singh Chouhan "Asymptomatic", Discharged From Hospital

Lupin Launches COVID-19 Drug Favipiravir In India At Rs 49 Per Tablet

NDTV News

Shares of Lupin were trading 0.32 per cent higher at Rs 943.70 apiece on BSE (Representational) New Delhi: Drug major Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name “Covihalt” for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India. Favipiravir has received … Read more Lupin Launches COVID-19 Drug Favipiravir In India At Rs 49 Per Tablet

Cadila's COVID-19 Vaccine Candidate Found Safe In Early-Stage Human Trial

NDTV News

Zydus Cadila said on Wednesday its COVID-19 vaccine candidate was found to be safe and well-tolerated in an early-stage human trial. The company will now start a mid-stage trial of the vaccine candidate, ZyCoV-D, in over 1,000 healthy adult volunteers from Thursday to test its effectiveness, it said in a regulatory filing. Zydus plans to … Read more Cadila's COVID-19 Vaccine Candidate Found Safe In Early-Stage Human Trial

Here's Why Sustainable Eating Is Even More Important During COVID-19 Pandemic

Here

Sustainable eating may become a viable practice in the long run. Highlights The global pandemic has encouraged consumption of local produce There is a growing emphasis on sustainable eating now more than ever Here’s why it is important to consider sustainable eating today The year 2020 marks an increasing inclination towards locally produced food. Gone … Read more Here's Why Sustainable Eating Is Even More Important During COVID-19 Pandemic

Lupin Launches Its Version Of Favipiravir Drug To Treat COVID-19

NDTV News

Lupin launched its version of Favipiravir drug Covihalt tablets on Wednesday Pharma major Lupin on Wednesday became the latest company to launch its version of the antiviral drug favipiravir to treat COVID-19. The drugmaker informed the exchanges about the same in a filing. ” Lipin today announced the launch of its Favipiravir in India under the … Read more Lupin Launches Its Version Of Favipiravir Drug To Treat COVID-19

Coronavirus Pandemic: 16 New COVID-19 Positive Cases Emerge At Toyota's Bidadi Plant

Toyota India resumed its operation at the Bidadi plant on July 20, 2020

Sixteen more cases of COVID-19 were reported at Toyota’s manufacturing plant in Bidadi, Karnataka. The infected employees had last attended work on 21st, 23rd, 24th, 28th, 29th, 30th, 31st July & 1st August, 2020. | Updated: 52 minutes ago 0  Views View Photos Toyota India resumed its operation at the Bidadi plant on July 20, … Read more Coronavirus Pandemic: 16 New COVID-19 Positive Cases Emerge At Toyota's Bidadi Plant

Zenara Pharma Receives Nod To Sell Covid-19 Drug Favipiravir

NDTV News

The tablet will be manufactured at Zenara’s US FDA approved facility in Hyderabad. Hyderabad-based Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, has received an approval from the Drugs Controller General of India (DCGI) to manufacture and sell Favipiravir tablets for treating patients with mild to moderate symptoms of Covid-19. The tablet, to … Read more Zenara Pharma Receives Nod To Sell Covid-19 Drug Favipiravir

OYO To Revoke Covid-19 Salary Deduction In Phased Manner, Starting This Month

OYO To Revoke Covid-19 Salary Deduction In Phased Manner, Starting This Month

The company had announced 25% salary deductions in April 2020 due to Covid-19 impact OYO’s CEO Ritesh Agarwal had said that the company’s revenues had dried up by 60% during the pandemic Even travel aggregator ixigo and edtech startup upGrad have reinstated the employees’ salaries from July After having a rough patch due to the … Read more OYO To Revoke Covid-19 Salary Deduction In Phased Manner, Starting This Month